efegatran has been researched along with Thrombophlebitis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Heran, CL; Michel, IM; Ogletree, ML; Schumacher, WA; Seiler, SM; Steinbacher, TE | 1 |
Bagdy, D; Bajusz, S; Barabás, E; Szabó, G | 1 |
2 other study(ies) available for efegatran and Thrombophlebitis
Article | Year |
---|---|
Comparison of thrombin active site and exosite inhibitors and heparin in experimental models of arterial and venous thrombosis and bleeding.
Topics: Amino Acid Sequence; Animals; Anticoagulants; Binding Sites; Bleeding Time; Carotid Artery Thrombosis; Disease Models, Animal; Dose-Response Relationship, Drug; Heparin; Male; Mesenteric Arteries; Molecular Sequence Data; Oligopeptides; Peptides; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Thrombin; Thrombophlebitis | 1993 |
Inhibition by D-MePhe-Pro-Arg-H (GYKI-14766) of thrombus growth in experimental models of thrombosis.
Topics: Amino Acid Sequence; Animals; Anticoagulants; Arteriovenous Shunt, Surgical; Disease Models, Animal; Male; Molecular Sequence Data; Oligopeptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Rats; Thrombophlebitis; Thrombosis | 1992 |